News

The latest data in our current survey highlights geographical differences in the comorbidities experienced by people with diabetes along with satisfaction with their glucose control.

People with Type 1 diabetes (PWT1) in Europe (EU) and the United States (USA) generally have similar access to diabetes technologies. So how do their health outcomes compare? dQ&A’s work shows that even with similar treatment plans, differing regional factors influencing diabetes management — such as obesity levels and the cost and accessibility of healthcare — potentially affect patient wellness.

In fifteen years of diabetes research, we’ve learned a lot about what drives successful outcomes...

New dQ&A data tracks GLP-1 & SGLT2 trends, patient/HCP insights, satisfaction, and market shifts to guide diabetes drug decisions.

Our research finds that 37% of people with diabetes report poor quality sleep, and about half suffer from restless sleep or have trouble staying asleep.

dQ&A Presented Three Abstracts at EASD 2023 | dQ&A

We partnered with LMC to connect real-world patient experience insights with validated clinical data for patients across the diabetes spectrum.

This study provides real-world evidence on hypoglycemia prevalence, its effects on people, and the implications for HCP & diabetes manufacturers.